CN1175852C - Medicine for treating hyperosteogeny - Google Patents
Medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1175852C CN1175852C CNB011363002A CN01136300A CN1175852C CN 1175852 C CN1175852 C CN 1175852C CN B011363002 A CNB011363002 A CN B011363002A CN 01136300 A CN01136300 A CN 01136300A CN 1175852 C CN1175852 C CN 1175852C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- hyperosteogeny
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating hypeosteogeny, which comprises the following raw materials: desertliving cistanche, atractylodes rhizome, coix seed, clematis root, achyranthes, net cliffbean, little multibanded krait, dragons'blood, obscured homalomena rhizome, doubleteeth pubesscent angelica root, eucommia bark, etc. The effective rate of the present invention for hyperosteogeny reaches more than 96%, and the present invention has special curative effect on various patients with a long course of disease and a serious state of disease.
Description
Invention field
The present invention relates to a kind of medicine for the treatment of hyperosteogeny, is a kind of Chinese medicine preparation that is used for the treatment of hyperosteogeny specifically.
Background technology
Hyperosteogeny is a kind of degeneration of bone.The category that belongs to " arthromyodynia ", " rheumatism involving the bone " in the traditional Chinese medical science.The method of treatment hyperosteogeny has a variety of, comprises operation, physical therapy, acupuncture, traction, block therapy etc.Treating this sick Chinese medicine also has a lot, for example discloses the patent of the medicine of many these class treatment hyperosteogenys in Chinese patent application is open.But some is owing to use the bigger raw material of toxicity, for example Semen Strychni, Scorpio, Scolopendra etc., and toxic and side effects is bigger.
Summary of the invention
The medicine that the purpose of this invention is to provide a kind of effective treatment hyperosteogeny, it reaches more than 96% the effective percentage of various hyperosteogenys, and have that taking convenience, safety, expense are low, no pain, characteristics such as have no side effect.Especially long to the course of disease, state of an illness weight person has better curative effect.
The inventor thinks that asthenia of both the spleen and kidney is the endogenous cause of ill of hyperosteogeny; Exopathogen is invaded, the labor desire is hindered is exopathogenic factor.The kidney being the origin of congenital constitution, and main store essential substances is given birth to the marrow bone growth promoting, the kidney essense abundance, and then bone marrow biochemistry is active, and skeleton is firm strong, and a little less than the deficiency of kidney-QI, then vital qi is weak, and kidney-jing deficiency is few, medullization source deficiency.The kidney being the origin of congenital constitution, needs the nourishing by the spleen day after tomorrow, and then asthenia of both the spleen and kidney is transported in insufficiency of the spleen mistake, and kidney is the dirty of cold water, rely the life fire with warm, deficiency of kidney-QI is subject to the exopathogen invasion and attack, the sitting standing for a long time is paddled in spite of the rain, sits the wetland that crouches, all can make deficiency of vital QI and to produce QI-blood circulation not smooth, pathogen is stopped up the anti-coagulating action plug, and blood stasis expectorant is turbid, tuberosity around the joint of a specified duration then takes place in the retardance meridians, gives birth to thorn, deformity, joint stuffiness, pain etc.
According to " according to this is arranged earlier; after mark is arranged; this does not remove, and mark does not go ", " pain is then obstructed; general rule is not bitterly " reach " QI and blood smoothness; all kinds of diseases and ailments are living ", the theory of " QI and blood is dull, and All kinds of diseases and ailments break out ", developed medicine of the present invention, reach the kidney invigorating, spleen invigorating, stomach function regulating, invigorate blood circulation, collateral dredging, antiinflammatory, remove thorn, the function of the pain of dispelling.
Medicine of the present invention is made by following raw material by weight:
Herba Cistanches 80-160 Rhizoma Atractylodis 40-120 Semen Coicis 20-60
Radix Clematidis 30-90 Radix Achyranthis Bidentatae 15-45 Radix Notoginseng 15-45
Caulis Spatholobi 30-90 Agkistrodon 6-18 Sanguis Draxonis 10-20
Cortex Eucommiae 10-30 Olibanum 10-30 Myrrha 10-30
Rhizoma Et Radix Notopterygii 15-45 Radix Angelicae Pubescentis 15-45 Cortex schizophragmatis integrifolii radicis 15-45
Rhizoma Homalomenae 15-45 Poria 15-45 Radix Saposhnikoviae 15-45
The optimum weight proportioning of medicine of the present invention is:
Herba Cistanches 120 Rhizoma Atractylodis 80 Semen Coiciss 40
Radix Clematidis 60 Radix Achyranthis Bidentataes 30 Radix Notoginseng 30
Caulis Spatholobi 60 Agkistrodons 12 Sanguis Draxonis 15
The Cortex Eucommiae 20 Olibanums 20 Myrrhas 20
Rhizoma Et Radix Notopterygii 30 Radix Angelicae Pubescentiss 30 Cortex schizophragmatis integrifolii radicis 30
Rhizoma Homalomenae 30 Poria 30 Radix Saposhnikoviaes 30
The method for preparing medicine of the present invention is: get above-mentioned raw materials, be ground into fine powder, sieve, be packaged into 6g and make powder for every bag.
Certainly, also medicine of the present invention can be made any dosage form that is suitable for using clinically, as pill, capsule, tablet, oral liquid etc.
Embodiment
Herba Cistanches 120g Rhizoma Atractylodis 80g Semen Coicis 40g
Radix Clematidis 60g Radix Achyranthis Bidentatae 30g Radix Notoginseng 30g
Caulis Spatholobi 60g Agkistrodon 12g Sanguis Draxonis 15g
Cortex Eucommiae 20g Olibanum 20g Myrrha 20g
Rhizoma Et Radix Notopterygii 30g Radix Angelicae Pubescentis 30g Cortex schizophragmatis integrifolii radicis 30g
Rhizoma Homalomenae 30g Poria 30g Radix Saposhnikoviae 30g
Get above-mentioned raw materials, be ground into fine powder, sieve, fully mix homogeneously is made the khaki Chinese powder medicine, and packing gets final product.Instructions of taking is each 6g, day clothes three times.
Evaluation of clinical curative effect
Medicine of the present invention is through the clinical verification of three more than ten years, thousands of cases, and evident in efficacy to hyperosteogeny, the bony spur at cervical vertebra, lumbar vertebra and other position of human body, total effective rate is more than 96%.Therefore, inventor's individual achievement, achievement are incorporated into own forces into " the well-known doctor expert of republic grand ceremony " (the national traditional Chinese medical science Ancient Books Publishing House publishes distribution in August, 2000).General hyperosteogeny is taken in 1-3 month and can thoroughly be cured, and the course of disease is long, the person of being in a bad way can take more than four months and cure.The speed of curing and the length of the course of disease, the position of hyperosteogeny, weight be about in general, the cervical spondylosis instant effect, cure also soon, most of hyperosteogeny is taken and can be fully recovered in one month, general about three months of hyperosteogeny, the most slowly be knee hyperplasia, generally needed cure in 4-6 month.The characteristics of this medicine are, and are without any side effects though the time of taking is long, and many patients take behind the some months not only hyperosteogeny and thoroughly cured, and also obtain curing if any chronic gastritis, rheumatism.Medicine of the present invention patient especially long to the course of disease, that be in a bad way has higher curative effect.
Now win the case that is in a bad way in recent years, curative effect is summarised in the following table, and to show the remarkable result of medicine of the present invention, wherein administration time is between 3 months to 6 months.
| The case sum | Clinical cure | Be clearly better | Slight improvement or not obvious | |
| Life, work capacity is seriously hindered or lose | 118 examples | 79 examples | 17 examples | 22 examples |
| Life, work capacity moderate are hindered | 293 examples | 245 examples | 31 examples | 17 examples |
By the result in the table as can be known, medicine of the present invention is 67% to the clinical cure rate of life, the impaired case of work capacity severe, total effective rate 81.3%, medicine of the present invention is 83.6% to the clinical cure rate of life, the impaired case of work capacity moderate, total effective rate is 94.2%.
Some cases is introduced
The hole prosperity, sugar refinery, Ningcheng County cadre, man suffer from cervical vertebra, hyperosteogeny more than ten years, once repeatedly arrived nonlocal large hospital treatment, expenses for medicine has been spent more than 20,000 yuan, and it is very little to take effect, and preferably causes hemianesthesia, neck dare not twist, misery can not be sayed, obeys medicine of the present invention recovery from illness in four months, and neck rotates freely now, arm wrist and waist shoulder pain disappear, and legs and feet are walked and recovered normal.
Ding Ruchun, ancient SHANGZI village two villagers in area just outside a city gate, Ningcheng County town, man, 76 years old, suffer from two more than ten years of hyperosteogeny, control every year, the units up to ten thousand that spend, always bad, 96 year winter paralysed on a heatable brick bed, body all can not turn over, and gnawing pains take no rest for one day twenty four hours, and the state of an illness is critical, the household has prepared funeral affairs for it, through taking medicine of the present invention, four first quarter moon times recoveries from illness are taken care of oneself, work capacity recovers normal now.
Claims (3)
1, a kind of medicine for the treatment of hyperosteogeny is characterized in that its active component is prepared from by following raw materials in weight portion:
Herba Cistanches 80-160 Rhizoma Atractylodis 40-120 Semen Coicis 20-60
Radix Clematidis 30-90 Radix Achyranthis Bidentatae 15-45 Radix Notoginseng 15-45
Caulis Spatholobi 30-90 Agkistrodon 6-18 Sanguis Draxonis 10-20
Cortex Eucommiae 10-30 Olibanum 10-30 Myrrha 10-30
Rhizoma Et Radix Notopterygii 15-45 Radix Angelicae Pubescentis 15-45 Cortex Illici difengpi 15-45
Rhizoma Homalomenae 15-45 Poria 15-45 Radix Saposhnikoviae 15-45.
2, according to the medicine of claim 1, wherein the weight portion proportioning of each raw material is:
Herba Cistanches 120 Rhizoma Atractylodis 80 Semen Coiciss 40
Radix Clematidis 60 Radix Achyranthis Bidentataes 30 Radix Notoginsengs 30
Caulis Spatholobi 60 Agkistrodons 12 Sanguis Draxonis 1
The Cortex Eucommiae 20 Olibanums 20 Myrrhas 20
Rhizoma Et Radix Notopterygii 30 Radix Angelicae Pubescentiss 30 Cortex Illici difengpi 30
Rhizoma Homalomenae 30 Poria 30 Radix Saposhnikoviaes 30.
3, prepare the method for the medicine of claim 1 or 2, comprise and get described raw material, be ground into fine powder,, make powder after sieve.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011363002A CN1175852C (en) | 2001-10-15 | 2001-10-15 | Medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011363002A CN1175852C (en) | 2001-10-15 | 2001-10-15 | Medicine for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1346670A CN1346670A (en) | 2002-05-01 |
| CN1175852C true CN1175852C (en) | 2004-11-17 |
Family
ID=4673563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011363002A Expired - Fee Related CN1175852C (en) | 2001-10-15 | 2001-10-15 | Medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1175852C (en) |
-
2001
- 2001-10-15 CN CNB011363002A patent/CN1175852C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1346670A (en) | 2002-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102872442B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN101972464B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN103893702A (en) | Traditional Chinese medicine composition for treating cervical spine bone hyperplasia and preparation method thereof | |
| CN102247497A (en) | Chinese patent medicine for treating rheumatoid arthritis | |
| CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN1235630C (en) | Chinese medicine paste for curing osteoarthropathy and preparing method | |
| CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
| CN1063338C (en) | Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny | |
| CN104825956A (en) | Medicine for preventing and treating stroke and recovering muscles, bones and joints | |
| CN1175852C (en) | Medicine for treating hyperosteogeny | |
| CN102600251B (en) | Rheumatism-rehabilitating traditional Chinese formulation | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN100542583C (en) | A kind of pharmaceutical composition for treating spinal and joint diseases | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN1058409C (en) | Medicine for quickly curing osteoproliferation | |
| CN1127974C (en) | Chinese medicine preparation 'Jiangudan' | |
| CN1562117A (en) | A kind of traditional Chinese medicine preparation for fast bone setting | |
| CN114272329B (en) | Traditional Chinese medicine composition for treating liver and kidney deficiency type cervical spondylosis, preparation and application | |
| CN101744901B (en) | Medicinal pillow for treating cervical spondylosis | |
| CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin | |
| CN1857636A (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN1250268C (en) | Fumigant | |
| CN1253186C (en) | Primordial qi strengthening plaster | |
| CN1695687A (en) | Medication for treating numbness of the muscles and painful joints |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |